These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2861096)

  • 41. Pharmacokinetic disposition of 14C-glyburide in patients with varying renal function.
    Pearson JG; Antal EJ; Raehl CL; Gorsch HK; Craig WA; Albert KS; Welling PG
    Clin Pharmacol Ther; 1986 Mar; 39(3):318-24. PubMed ID: 3081293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of ticarcillin and clavulanic acid (timentin) in relation to renal function.
    Jungbluth GL; Cooper DL; Doyle GD; Chudzik GM; Jusko WJ
    Antimicrob Agents Chemother; 1986 Dec; 30(6):896-900. PubMed ID: 3492959
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function.
    Aweeka F; Jayesekara D; Horton M; Swan S; Lambrecht L; Wilner KD; Sherwood J; Anziano RJ; Smolarek TA; Turncliff RZ
    Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):27S-33S. PubMed ID: 10771451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The influence of renal function on the pharmacokinetics of unchanged and acyl-glucuroconjugated ketoprofen enantiomers after 50 and 100 mg racemic ketoprofen.
    Skeith KJ; Dasgupta M; Lange R; Jamali F
    Br J Clin Pharmacol; 1996 Aug; 42(2):163-9. PubMed ID: 8864313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Steady-state intravenous pharmacokinetics of pirenzepine in patients with differing degrees of renal dysfunction.
    Krakamp B; Tanswell P; Vogel H; Bozler G
    Eur J Clin Pharmacol; 1989; 36(1):75-8. PubMed ID: 2917593
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of ceftazidime in patients with renal insufficiency.
    Welage LS; Schultz RW; Schentag JJ
    Antimicrob Agents Chemother; 1984 Feb; 25(2):201-4. PubMed ID: 6370127
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The effect of H2 receptor blockers on renal function. An attempt to accurately measure glomerular filtration].
    Motyl W
    Ann Acad Med Stetin; 2004; 50(1):97-105. PubMed ID: 16871748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pharmacokinetics of temocillin in patients with normal and impaired renal function.
    Boelaert J; Daneels R; Schurgers M; Lambert AM; Van Landuyt HW; Mellows G; Wolf J; Swaisland AJ
    J Antimicrob Chemother; 1983 Apr; 11(4):349-56. PubMed ID: 6853404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elimination kinetics of mezlocillin in normal and impaired renal function including the effects of dialysis.
    Kosmidis J; Doundoulaki P; Stathakis C; Zerefos N; Bounia A; Daikos GK
    Arzneimittelforschung; 1979; 29(12a):1960-2. PubMed ID: 543901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of carumonam in patients with renal insufficiency.
    Horber F; Egger HJ; Weidekamm E; Dubach UC; Frey FJ; Probst PJ; Stoeckel K
    Antimicrob Agents Chemother; 1986 Jan; 29(1):116-21. PubMed ID: 3729324
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disposition kinetics of disopyramide in patients with renal insufficiency.
    Shen DD; Cunningham JL; Shudo I; Azarnoff DL
    Biopharm Drug Dispos; 1980; 1(3):133-40. PubMed ID: 7448340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of cefotiam in patients with impaired renal function and in those undergoing hemodialysis.
    Konishi K; Ozawa Y
    Antimicrob Agents Chemother; 1984 Nov; 26(5):647-51. PubMed ID: 6097172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of vancomycin in patients with various degrees of renal function.
    Matzke GR; McGory RW; Halstenson CE; Keane WF
    Antimicrob Agents Chemother; 1984 Apr; 25(4):433-7. PubMed ID: 6732213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of famotidine on oxidative drug metabolism.
    Somerville KW; Kitchingman GA; Langman MJ
    Eur J Clin Pharmacol; 1986; 30(3):279-81. PubMed ID: 2874031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospective evaluation of ten methods for estimating creatinine clearance in children with varying degrees of renal dysfunction.
    Paap CM; Nahata MC
    J Clin Pharm Ther; 1995 Apr; 20(2):67-73. PubMed ID: 7650077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of oral cefatrizine in patients with impaired renal function.
    Couet W; Fauvel JP; Laville M; Pozet N; Fourtillan JB
    Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):213-7. PubMed ID: 1869342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cimetidine versus famotidine: the effect on the pharmacokinetics of theophylline in rats.
    Mojaverian P; Rocci ML; Saccar CL; Vlasses PH; Ferguson RK
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):155-9. PubMed ID: 2864251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cefsulodin pharmacokinetics in patients with various degrees of renal function.
    Matzke GR; Keane WF
    Antimicrob Agents Chemother; 1983 Mar; 23(3):369-73. PubMed ID: 6847169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral flecainide pharmacokinetics in patients with impaired renal function.
    Forland SC; Burgess E; Blair AD; Cutler RE; Kvam DC; Weeks CE; Fox JM; Conard GJ
    J Clin Pharmacol; 1988 Mar; 28(3):259-67. PubMed ID: 3129455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of effect of impaired renal function on lamivudine pharmacokinetics.
    Bouazza N; Tréluyer JM; Ghosn J; Hirt D; Benaboud S; Foissac F; Viard JP; Urien S
    Br J Clin Pharmacol; 2014 Oct; 78(4):847-54. PubMed ID: 24750102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.